Skip to main content

1 Result(s)

within Fengge Wang Remove this filter Medicine & Public Health Remove this filter Drug Safety and Pharmacovigilance Remove this filter

and

  1. No Access

    Article

    SGLT2 Inhibitor Use and Risk of Breast Cancer Among Adult Women with Type 2 Diabetes

    Sodium–glucose cotransporter 2 (SGLT2) inhibitors are a relatively new class of antihyperglycemic agents, with the potential to inhibit breast cancer development. However, the association between SGLT2 inhibit...

    Fengge Wang, Michael Hendryx, Nianjun Liu, Aurelian Bidulescu… in Drug Safety (2024)